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Abstract 
Escherichia coli comprises a highly diverse group of Gram negative bacteria and is a common member 
of the intestinal microflora of humans and animals. Generally, such colonisation is asymptomatic, 
however, some E. coli strains have evolved to become pathogenic and thus cause clinical disease in 
susceptible hosts. One pathotype, the Shiga toxigenic E. coli (STEC) comprising strains expressing a 
Shiga-like toxin is an important foodborne pathogen. A subset of STEC are the enterohaemorrhagic E. 
coli (EHEC) which can cause serious human disease, including haemolytic uraemic syndrome (HUS). 
The diagnosis of EHEC infections, and the surveillance of STEC in the food chain and the environment, 
require accurate, cost-effective and timely tests. In this review we describe and evaluate tests now in 
routine use, as well as up-coming test technologies for pathogen detection, including loop-mediated 
isothermal amplification (LAMP) and whole genome sequencing (WGS). We have considered the need 
for improved diagnostic tools in current strategies for the control and prevention of these pathogens 
in humans, the food chain and the environment. We conclude, that although significant progress has 
been made, STEC still remains an important zoonotic issue worldwide. Substantial reductions in the 
public health burden due to this infection will require a multi-pronged approach, including ongoing 
surveillance with high resolution diagnostic techniques currently being developed and integrated into 
the routine investigations of public health laboratories. However, additional research requirements 
may be needed before such high resolution diagnostic tools can be used to enable the development 
of appropriate interventions, such as vaccines and decontamination strategies.   
 
 
1. Introduction 
Escherichia coli comprises a highly diverse group of Gram negative bacteria with a wide range of 
habitats, physiological characteristics and pathogenic associations for animals and humans. E. coli is a 
common member of the intestinal microflora of humans and animals. Generally such colonisation is 
asymptomatic, however, some E. coli strains have evolved to become pathogenic and thus cause 
clinical disease.  
When colonising the human or animal intestinal tract such strains usually cause diarrhoea, but may 
also transit the intestinal mucosa to result in systemic infections. Other pathogenic E. coli strains, such 
as the uropathogenic E. coli (UPEC) and avian pathogenic E. coli (APEC) have evolved to colonise 
extraintestinal sites. In the case of UPEC and APEC the primary site of infection are the urogenital tract 
of humans and the respiratory tract of birds, respectively. Such strains are termed Extraintestinal E. 
coli (ExPEC). 
The nomenclature for E. coli strains is extremely complex and confounded by historical terminology. 
Unfortunately with newly acquired data from technology such as whole genome sequencing, this 
terminology is becoming even more confusing.  
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In humans, diarrhoeic strains of E. coli (DEC) have been divided into at least 5 pathotypes 
(Enteropathogenic E. coli (EPEC), Shiga toxigenic E. coli (STEC) (of which Enterohaemorrhagic E. coli 
(EHEC) are a subset), Enteroaggregative E. coli (EAEC), Enterotoxigenic E. coli (ETEC), and 
Enteroinvasive E. coli (EIEC)), a classification reflecting the pathology induced during infection and to 
some extent the virulence factors they express. The enterohaemorrhagic E. coli (EHEC) have been of 
particular concern as a zoonotic and foodborne infection because of the low infectious dose (<100 
organisms) and serious nature of the disease, especially in young children, the immunocompromised 
and the elderly (Karmali, 1989).  
 
All EHEC strains express a Shiga toxin-like activity and are, therefore, a subset of an E. coli pathotype 
known as STEC (Shiga toxigenic E. coli). Historically such strains are also known as Verotoxigenic E. coli 
(VTEC) reflecting the ability of this toxin to induce morphological changes in Vero tissue culture cells 
(an African green monkey kidney cell line) in vitro (Konowalchuk, Speirs & Stavric, 1977), which in the 
past was commonly used as a diagnostic test. For the purpose of this review STEC and VTEC are treated 
as synonymous and STEC will be the preferred terminology used. Colonisation with STEC strains can 
cause a spectrum of outcomes in humans, including mild to severe diarrhoea, however, the subset of 
STEC strains termed EHEC are specifically associated with causing human haemorrhagic uraemic 
syndrome (HUS). The EHEC strain E. coli O157:H7 is the most-well recognised and is used as a 
representative of the STEC pathotype. STEC strains have also been associated with diseases in 
livestock, for example, oedema disease in pigs and swollen head syndrome in poultry (Marques, Peiris, 
Cryz & O’Brien, 1987).  
The objective of this chapter is to review EHEC and other STEC strains with particular focus on those 
characteristics relevant to their detection in human disease and in livestock reservoirs and the food 
chain, in order to reduce the public health burden of the disease in humans. There are many literature 
reviews of the clinical aspects of this infection, so to avoid repetition and where relevant, we will only 
reference these.  
As with many zoonotic foodborne bacterial infections, disease associated with STEC is primarily 
observed in humans, while the livestock reservoirs remain largely unaffected by colonisation with this 
bacterial agent. In consequence, approaches to STEC detection have tended to focus on the need for 
specific and sensitive tests to diagnosis the disease in humans. However, in order to undertake the 
surveillance necessary to control and prevent disease transmission to humans from the animal 
reservoirs, appropriate methods are needed to detect the pathogen in all potential sources and routes 
including animals, foods and the environment.  
There have been numerous reviews of E. coli O157:H7 pathogenesis, epidemiology and control, and 
more recently, additional general STEC reviews. The current review has been undertaken within the 
remit of the DISCONTOOLS project (http://www.discontools.eu). DISCONTOOLS was originally 
developed under the EU funded FP7 programme and aims to meet the challenges of future food 
supplies by developing prioritisation methodology and gap analysis for new or improved diagnostics, 
vaccines and pharmaceuticals for target diseases. Here we aim to highlight current research challenges 
for the investigation, diagnosis, prevention and control of STEC (see Table 1). In particular we will focus 
on the role that novel and innovative detection and diagnostic techniques can play in meeting these 
challenges. Where relevant we will refer to other more comprehensive literature, but in order to 
describe current challenges and assess the value of available tools it will be necessary to provide a 
brief overview of the properties of these organisms and their infections. Primarily, we will focus STEC 
in the European environment consistent with the DISCONTOOLS aims and objectives. We will use 
available European data to illustrate statements and support opinions but other data will be included 
where relevant. 
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2. Disease and pathogenicity: 
Most of our knowledge about the pathogenicity of STEC is derived from research on strains of E. coli 
O157:H7 as this is the strain most commonly isolated from HUS patients and is, therefore, considered 
representative of EHEC strains. The known pathogenicity mechanisms of EHEC strains have been 
extensively reviewed elsewhere (for example Stevens and Frankel, 2014), however, the 
representativeness of laboratory E. coli O157:H7 strains of other STEC, or even of all O157:H7 strains, 
is debatable. It is well-recognised that the attenuation of laboratory strains of enteric pathogens 
through repeated passage can have significant effects on pathophysiological properties (Newell, 
Manning, Goldberg, Morgan, & Wassenaar, 2016).  
In humans the clinical presentation of gut colonisation with E. coli O157:H7 ranges from asymptomatic 
carriage, through non-bloody diarrhoea to haemorrhagic colitis and haemorrhagic uraemic syndrome 
(HUS) (Karmali, Petric, Lim, Fleming & Steele, 1983). HUS can lead to thrombocytopaenia, haemolytic 
anaemia and ultimately kidney failure. 
The pathogenicity of E. coli O157:H7 starts with colonisation of the intestinal mucosa following 
ingestion of contaminated food or water. The infectious dose is extremely low (<100 organisms) 
apparently reflecting the bacterium's ability to withstand the acidic environment of the stomach 
(Foster, 2004). Whether the dose response is similar for all STEC strains is unknown. Certainly, 
epidemiological evidence indicates significant variability in the incidence rates during O157:H7 
outbreaks. Such variability could have substantial effects on the outputs of risk assessment models 
(Teunis, Ogden, & Strachan, 2008; Newell et al., 2016). Moreover, recent studies have focused on how 
STEC interfaces with the normal microbiota and how the normal microflora may influence 
susceptibility to infection (Bian et al., 2016). 
Efficient intestinal colonisation requires bacterial motility to reach the intestinal mucosa and then 
attachment of the bacterium to host enterocytes for effective systemic delivery of bacterial toxins. 
EHEC strains are generally considered non-invasive pathogens but this may not be true for all STEC 
strains (Rogers, Thorpe, Paton & Paton, 2012).  
Bacterial motility is mediated by active flagella, which are considered essential accessory virulence 
factors for many enteric pathogens, including STEC (Yang et al., 2013) but non-motile E. coli strains 
can also be pathogenic and of course non-pathogenic E. coli are often motile. So presence of flagella 
is not a definitive virulence factor. Nevertheless, flagellin is encoded by the fliC gene and because 
certain flagellin antigen types dominate within pathogroups of E. coli, flagella may have additional 
roles in virulence including adherence and innate immunity (Smith et al., 2003), and host association.  
E. coli expresses a number of fimbrial and non-fimbrial adhesins, which are involved in attachment to 
a greater or lesser extent (La Ragione, Cooley & Woodward, 2000). Much of our knowledge of E. coli 
fimbrial adhesins has been gained from research on EPEC strains (Cleary et al., 2004) and EPEC 
adhesins that have been associated with intestinal colonization include bundle-forming pili (BFP), EspA 
filaments and intimin. Other fimbrial types documented for STEC include AAF/I and LPF (McWilliams 
& Torres, 2014; Nagy, Xu, Bauchan, Shelton, & Nou, 2016; Ross, Rojas-Lopez, Cieza, McWilliams, & 
Torres, 2015). 
However, For EHEC strains attachment appears to be primarily mediated by the outer membrane 
protein adhesin, intimin, encoded by the eae gene localised within a ~35kb chromosomal 
pathogenicity island termed the Locus of Enterocyte Effacement (LEE). The presence of the LEE locus 
and eae gene have been considered indicative of EHEC (EFSA, 2013), but LEE- and eae-negative STEC 
can also cause severe disease including HUS (Franz et al., 2015). In some E. coli pathotypes, such as 
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EAEC, adherence and long-term gut colonisation are also associated with the capacity to form biofilms 
and biofilm formation may also influence the pathogenesis of STEC (Villegas et al., 2013).  
The attachment process involves the induction of characteristic attaching and effacing (AE) lesions in 
the luminal surface of the host intestinal cells (Donnenberg & Kaper, 1991). AE lesion formation 
requires Tir (Translocated intimin receptor). This receptor is translocated into the host cell by a type 
3-secretion system (T3SS) (Jarvis et al., 1995), which provides the complex structure required to span 
the host cell membranes and enable the entrance of bacterial effectors into the host cell cytoplasm. 
Bacterial attachment is then associated with host cell F-actin condensation, the induction of a pedestal 
and microvillus effacement. This intimate attachment allows the effective systemic delivery of the E. 
coli toxin(s).  
In LEE-negative STEC strains alternative mechanisms for gut colonization are employed. In some non-
LEE STEC strains Long Polar Fimbriae (Lpf), encoded by lpfA genes, appear to enable adhesion and 
colonisation (Galli Torres & Rivas, 2010) while in other strains, such as O113:H21, which do not 
produce adherence factors (Feng et al., 2014), in vitro invasion of intestinal epithelial cells is largely 
dependent on flagellin expression (Rogers et al., 2012). Thus, the absence of LEE and eae in STEC 
strains cannot be used to exclude the potential to cause severe human disease (Franz et al., 2015). 
In 1997 Konowalchuk et al. demonstrated that that a subset of E. coli produced potent toxins, which 
were heat label and unlike previously identified E. coli heat-labile enterotoxins (LTs). These toxins 
caused Vero cells to round up and die and were antigenically cross-reactive with the toxin (Stx) 
produced by Shigella dysenteriae 1 (O’Brien & LaVeck, 1983). In consequence the toxin was named 
Shiga toxin 1 (Stx1). Subsequently, a similar toxin Stx2 with distinguishable antigenicity and toxicity 
was identified. Several subtypes of these two toxins (Stx1 a, c and d and Stx2 a, b, c, d, e, f and g) have 
now been described with varying disease associations in humans (Scheutz et al., 2012; Franz et al., 
2015) and colonisation properties in cattle (Dallman, et al., 2015a). Some EHEC strains express 
multiple Stx subtypes (Shaaban et al., 2016). 
The genes for Stx, and various effector proteins of the T3SS, are encoded on integrated bacteriophages 
(prophages) distributed around the EHEC genome. Prophages are also involved in the regulation of 
Shiga toxin production. Such prophages have played an important role in the evolution of EHEC 
(Kruger and Lucchesi, 2015; Shaaban et al., 2016), and the emergence of new STEC strains. The 
considerable diversity of stx genes, and variations in their stx prophage environment affect the 
virulence of STEC strains.  
Because the genome of E. coli is plastic and prophage uptake is a common event, Stx expression is not 
confined to EHEC. Stx-producing enteroaggregative E. coli (EAEC) have characteristics of both 
pathotypes and can induce severe disease, including HUS, as demonstrated by the outbreak of E. coli 
104:H4 in Germany in 2011 (Frank et al., 2011). These strains may not possess the eae gene, but have 
genes associated with enteroaggregative adhesion by which they can be identified, such as aggR, 
which is located on a plasmid and regulates the aggregative adherence fimbriae pathogenicity island 
(AFF PAI). Because plasmid loss can occur the EAEC pathotype is also identified by the presence of 
aaiC, which is chromosomally located and encodes a secreted protein of EAEC (EFSA, 2013).  
The Stx toxins are transported across the intestinal barrier to access the systemic circulation and reach 
susceptible tissues expressing the glycosphingolipid cell receptor Gb3. The structure and activity of 
the Stx toxins are well known (Melton-Celsa, 2014). In humans the endothelial cells of the kidney are 
the major targets causing inhibition of protein synthesis and triggering apoptosis. The damage to the 
glomerular structure activates platelets, resulting in a coagulation cascade and initiating an 
inflammatory response. Localised thrombi formation in the glomerulus can cause thrombocytopaenia 
purpura and haemolytic anaemia. The resulting impairment of the renal vasculature is characteristic 
of HUS (Obrig & Karpman, 2012). In addition, Stx can also bind to Gb3 on the surface of cells of the 
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central nervous system causing neurological symptoms including epileptic seizures (Nathanson et al., 
2010).  
Because the distribution of Gb3 receptors throughout the body varies with host species, susceptibility 
to the toxic effects of Stx also varies from one species to another. For example the tolerance of cattle 
to STEC colonisation is ascribed to the lack, or different distribution, of Gb3 receptors in their 
gastrointestinal tract and internal organs (Pruimboom-Brees et al., 2000; Hoey et al., 2002).  
Increasingly, evidence indicates that infection with STEC strains results in varying clinical outcomes, 
presumably due to a combination of differences in patient susceptibility and strain virulence 
properties. With the increasing availability of whole genome sequences of STEC strains and data 
mining using pipelines and predictive algorithms, investigations suggest that only a small proportion 
of even O157 strains, perhaps as few as 10%, have the potential to cause human disease. Furthermore, 
this virulence potential is likely associated with the abundance of genes encoding prophage proteins 
(Lupolova, Dallman, Matthews, Bono & Gally 2016). The ability to rapidly and accurately distinguish 
between those human STEC infections which will result in severe as opposed to mild symptoms is a 
major clinical requirement so that appropriate and timely patient treatment can be provided. 
Unfortunately, to date, no clear association between the presence or absence of known virulence 
factors and the severity of infection has been identified (Franz et al., 2015). Although Stx2-producing 
strains appear more virulent than Stx1-producing strains (Beutin et al., 2008), and certain Stx subsets 
have a greater disease potential than others (Shaaban et al., 2016), clearly other virulence factors, 
such as adhesins, are also involved (Franz et al., 2015). Therefore, it appears that strain virulence is 
determined by sets of multiple genes and that the gene content of such sets can vary. Defining the 
essential gene content for virulence and persistence is now a primary research need in order to 
provide accurate predictive hazard assessment. Of course, improved knowledge of the pathogenic 
diversity and mechanisms of non-O157, as well as O157 STEC strains, will be an underpinning 
requirement to the development such tools.  
 
3. Epidemiology, source attribution and risk assessment  
The efficient monitoring and surveillance of all human foodborne infections is considered crucial to 
the implementation of effective interventions. Methods of epidemiological investigation are 
constantly evolving. In particular new techniques, which will be addressed later, to detect foodborne 
pathogens and discriminate between strains are having a significant impact on source identification 
and risk assessment.  
In European countries there has been a long history of the epidemiological investigation and source 
tracing of foodborne bacterial disease, data from which is now collected in comprehensive and well 
analysed annual reports from the European Union (EU) highly suitable for illustrating epidemiological 
characteristics of these infections. For E. coli where non-pathogenic strains are common in multiple 
hosts and the environment, and potentially highly pathogenic strains need to be correctly identified 
especially in clinical isolates, subtyping has been an essential tool in epidemiological investigations. 
Historically, in Public Health laboratories world-wide, the then existing skills and expertise in 
serotyping encouraged the wide-spread adoption of this subtyping technique for E. coli. There are two 
serotyping schemes for E. coli based on the O (lipopolysaccharide (LPS)) and H (flagellar) antigens and 
these tend to be used in parallel. Both use antisera in simple agglutination assays. To date over 180 E. 
coli O-serogroups and over 50 H-serotypes have been identified (Ingle et al., 2016) and there are more 
than 100 serotypes of STEC associated with human disease (Ferdous et al., 2016). Surveillance of STEC 
infections is often undertaken using serotyping (full or partial) only or using methods which only 
recover and identify O157:H7 strains. 
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Since the O104:H4 outbreak in Germany in 2011 (Frank et al., 2011) there has been increasing pressure 
on public health services to strengthen and broaden STEC surveillance in animals, humans and food. 
In particular, there is a call for enhanced HUS surveillance in children under 5, especially for non-O157 
sero-pathotypes (Severi et al., 2016). 
Human infections with STEC strains are reported worldwide, both as sporadic and outbreak-associated 
cases. The notification of human STEC infections is mandatory in most the EU member states. In 2015, 
5901 cases of STEC infection were confirmed in the EU, (EFSA, 2016). The EU incidence of disease has 
now been reported for over 15 years. In addition, isolated STEC strains are routinely serotyped using 
the O typing scheme. Such longitudinal surveillance indicates that STEC disease is dynamic with 
incidence changing over time and geographical location (EFSA, 2016) and season (Garvey et al., 
2016a). Moreover, the strains causing the disease are also changing over time (EFSA, 2016), suggesting 
evolving differences in sources and transmission vehicles (Adams et al., 2016; Óhaiseadha, Hynds, 
Fallon & O’Dwyer, 2017). Thus there is a clear ongoing requirement for the active surveillance of STEC 
disease and infecting strains, with standard approaches to identify emerging trends and enable 
historical comparison.  
Using a combination of serotype, the reported frequency of infection, severity of disease and 
association with outbreaks Karmali et al. (2003) were able to divided STEC into seropathotypes A-D 
which has informed epidemiological studies and supported risk assessment. However, with the 
exception of E. coli O157:H7, which is a relatively stable clone (Liesegang et al., 2000), the relationship 
between serotype and disease potential is generally poor (Franz et al., 2015). In the investigation of 
EU infections the identification of HUS-associated strains can apparently be improved by adding health 
outcome and laboratory confirmation to the epidemiological analysis (Messens et al., 2015). 
Nevertheless, the most useful future epidemiological tools for strain differentiation will require the 
inclusion of appropriate virulence factors using genetic screening approaches. However, in addition 
to stx gene types and subtypes, the combinations of virulence factors required to generate a 
pathogenic organism are, as yet, unknown.  
The sources of STEC infection causing disease in humans have been extensively investigated. STEC can 
colonise a wide range of animals and the majority of this bacterial population probably reside in 
asymptomatically colonised animal hosts. Using classical epidemiological studies, including outbreak 
and case-control analyses, and molecular epidemiological approaches, source attribution studies 
identify ruminants, especially cattle, as a major reservoir and the food chain as a significant 
transmission route (Pennington, 2010; Mughini-Gras et al., 2017) as well as person-to-person spread 
(Garvey, Carroll, McNamara, & McKeown,  2016b).  
The primary site of colonisation in cattle is the terminal rectum where the bacteria form attaching and 
effacing lesions on the apical epithelial surface, but colonisation is generally asymptomatic (Naylor et 
al., 2003), although histopathological effects are observed, so the organism is not a commensal in this 
environment (Naylor et al., 2007). Cattle faeces containing excreted organisms contaminate hides and 
subsequently meat during slaughter and processing, but can also contaminate milk (Severi et al., 
2016).  
Other ruminant and non-ruminant livestock, including sheep, goats, pigs and chickens, can also be 
asymptomatically colonised with, and excrete, STEC especially E. coli O157 (Best et al., 2006, 2009; La 
Ragione et al., 2005; Wales et al., 2005), though the pathobiology may vary from that in cattle (La 
Ragione, Best, Woodward & Wales, 2009). All such colonisation may contribute to contamination of 
farm environments, including ground water, constituting a significant risk factor of human disease, 
particularly for rural communities (Óhaiseadha et al., 2017). 
There have been multiple studies on the risk factors for cattle colonisation and excretion, including 
environmental factors such as season, rainfall, temperature, latitude of farm and relative humidity; 
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animal factors such as age, breed, colostrum deprivation in calves and stress levels; and farm 
husbandry factors such as feed, group size, new animals incorporated into the herd, housing, water 
supply, and positive animals in the proximity (Jaros et al., 2016; Rugbjerg, Nielsen & Andersen, 2003; 
Smith, Pollitt & Paiba, 2016; Venegas-Vargas et al., 2016; Widgren et al., 2016; Williams, Ward, 
Dhungyel & Hall, 2015).  
Some cattle are recognised to be "Super shedders", which can substantially increase the risk of herd 
colonisation and environmental contamination (Chase-Topping, Gally, Low, Matthews & Woolhouse, 
2008). The super shedding status of cattle is related to degree of colonisation of the lymphoid follicle-
dense mucosal region close to the recto-anal junction (Cobbold et al., 2007; Low et al., 2005).  
There are few national surveys of STEC in livestock, however, throughout 2003 a national survey of E. 
coli O157 carriage by animals at slaughter was undertaken in Great Britain. This survey indicated that 
carriage was 4.7% in cattle, 0.7% in sheep and 0.3% in pigs (Milnes et al., 2008). STEC detected in food 
and animals is now recorded annually by EU member states and technical guidelines have been issued 
to enable the standardisation of sampling and STEC detection (EFSA, 2016). These guidelines 
recommend that detection methods used should recover all STEC strains and that recovered strains 
should be serotyped to enable comparative surveillance with human isolates. The EU Summary Report 
on Zoonoses, Zoonotic Agents and Food-borne Outbreaks now records STEC recovered from all 
ruminants, including goats, sheep and deer, as well as pigs, cats, dogs and solipeds. This data 
demonstrates that cattle are not the only potential reservoir of infection. Overall 6.8% of all animals 
tested (n=6881) were STEC positive. The highest prevalence was in sheep and goats (18.5%) compared 
to 8.3% in cattle and 8.3% in pigs. For those isolates where typing methods were applied serogroup 
O157 constituted less than half of the STEC reported in sheep (5.6%) and cattle (2.7%).  
Food monitoring in the EU supports the role of bovine and other ruminant meats as sources of human 
infection with 1.6% of bovine meat and 12.1% of sheep/goat meats contaminated with STEC in 2015 
(EFSA, 2016). Monitoring also detected contamination in 1.8% of samples of raw cow's milk. Although 
the proportion of samples of foods contaminated with serogroup O157 was substantially lower, most 
of the STEC strains recovered were associated with human disease in the EU.  
For some time there has been increasing awareness worldwide that fresh produce, such as fruits, 
vegetables and seeds, can also be vehicles of transmission for STEC infections. For example, the 
outbreak in Germany and France in 2011, involving about 4000 cases with over 50 deaths, was 
epidemiologically-linked to sprouting seeds (Frank et al., 2011). Fresh products are frequently grown 
in soils fertilised or contaminated with animal waste and/or irrigated with brown water, which can 
lead to plant contamination on harvesting (Mishra, Pang, Buchanan, Schaffner & Pradhan, 2017). STEC 
is capable of an endophytic lifestyle (Wright et al., 2013) enabling attachment to, and survival in, plant 
material and even protection from post-harvest disinfection processes. The organism survives well in 
the rhizosphere of vegetable plants and can colonise plants both externally and internally. 
Internalisation and phylosphere survival are dependent on the inoculum, plant age, plant type and the 
presence of insects as well as the bacterial capacity to express various virulence factors (Ongeng et 
al., 2015). 
The detailed epidemiological investigations undertaken on outbreaks over the last 30 years have 
allowed the sources and routes of transmission of O157 STEC human infections to be generally well 
understood. However, the increasing surveillance called for O157 and, most recently, non-O157 
strains (Ferdous et al., 2016), is demonstrating the widespread presence of STEC in livestock, foods, 
water and the environment. In order to develop and implement appropriate risk management 
strategies the relative importance of these strains in human disease needs to be determined. In 
particular the capacity to subtype strains and differentiate between levels of virulence as predictors 
of severity of human disease is an urgent requirement. To date phenotypic and molecular 
epidemiological techniques have had limited success at addressing these questions. However, the 
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recent adoption of whole genome sequencing (WGS) accompanied by developments in pan-genomic 
pipelines and, in particular, the use of machine learning algorithms, for example the Support Vector 
Machine (SVM), (Lupolova, Dallman, Matthews, Bono & Gally, 2016) are beginning to provide novel 
information about the proportion of strains which can cause human disease (see section 7.2.2.3). 
Unfortunately, such approaches are currently highly dependent on expert bioinformaticists/ 
mathematicians/statisticians, who use dedicated and jargon-ladened language largely uninterpretable 
by non-expert clinicians and clinical microbiologists. Therefore, there is an evident need for 
compromise to ensure best benefit of such technological advances. The bioinformaticists need to 
learn to talk at an acceptable level to, and work with, their less expert colleagues. On the other hand 
non-experts need appropriate level education resources such as simple learning texts (for example 
Ussery, Wassenaar and Borini, 2009), but which need to be frequently up-dated to keep up with the 
enormous speed of development in this scientific field.    
 
4. Socio-economic impact including zoonotic aspects  
STEC strains can colonise a wide range of hosts but are considered primarily a foodborne disease 
problem in humans causing both outbreaks and sporadic cases. Majowicz et al. (2014) have recently 
estimated the global public health burden of infections with STEC strains to include 2,801,000 cases 
of acute illness, 3890 cases of HUS, 270 cases of end stage renal disease (ESRD) and 230 deaths per 
year. HUS is one of the most serious sequelae of STEC infection and is a particular problem in the 
young. In 2015 HUS was reported in 65% of infected children under the age of 5 years and 20% of 
infected children aged 5-14 years old in the EU (EFSA, 2016). 
Despite such case numbers, analyses from the Netherlands (van Lier et al., 2016) indicates that the 
relative importance of E. coli O157:H7 as a foodborne disease, in terms of disability-adjusted life years 
(DALYS), is significantly lower than that of toxoplasmosis, campylobacteriosis, salmonellosis or 
norovirus infections. Similarly the foodborne diseases salmonellosis and campylobacteriosis are 
considered of a greater public health burden than O157:H7 in the United Kingdom (O’Brien et al., 
2016). Nevertheless, STEC infection remains an important cause of morbidity and mortality 
worldwide.  
In 2015 5901 cases of STEC infection were reported in the EU (EFSA, 2016), of which 41% were due to 
O157, but the disease is considered to be significantly under-reported. The estimated disease 
multiplier for STEC O157 and non-O157 are 51.2 and 209.6 respectively (EFSA, 2013). Over one third 
(36%) of cases of STEC infection were reported as hospitalised, with an overall case fatality rate 
reported at 0.2% but the outcome of such infections are not always recorded. The risk of 
hospitalisation varies with the serogroup of the infecting strain. STEC O157 infection has a higher risk 
of hospitalisation (68%) than all non-O157 infections (less than 1%), excepting serogroup O104 (46%) 
(Preußel, Höhle, Stark, & Werber 2013). However, infections with both O157 and O104 strains have 
similar mortality risks, which are about 10 fold more than infections with strains of other serogroups.  
As with many foodborne infections, the cost of the STEC disease is largely borne by the public health 
system because gut colonisation is usually asymptomatic in livestock. The costs to public health in 
terms of clinical care and outbreak investigation can be huge (Pennington, 2010). However, as a 
consequence of epidemiological investigations, sources of infection are now often identified and can 
result in legal action. Moreover, product recall can be a substantial cost to the industry. For example, 
in an outbreak in Odwalla, USA associated with unpasteurised apple juice, product recall costs alone 
were $6.5 million (Pennington, 2010). 
Prioritization of the use of public health resources is a major problem for most countries. The data and 
tools required to undertake the comparative estimation of burdens of acute foodborne diseases have 
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only recently been developed (Newell et al., 2010). These tools can now provide relative indicators of 
global and national social-economic costs using approaches largely led by the World Health 
Organization's Foodborne Disease Burden Epidemiology Reference Group (FERG) (Havelaar et al., 
2015). Such approaches now need to be applied to at national levels to enable governments and 
regulatory authorities to set targets for the control and prevention of STEC infections.  
 
5. Prevention and control 
The direct prevention and control of human STEC infections is difficult because of the diversity of 
infecting strains and the wide variety of sources and routes of transmission for these pathogens. 
Attempts to prevent or treat human colonisation using probiotics or dietary supplements or 
modifications have had little evidence of success and at worse may be detrimental (Thorpe et al., 
2017) to the patient. Thus the management of human STEC infection currently remains restricted to 
supportive clinical care. 
The consensus opinion is that the public health burden of STEC infection is best reduced by controlling 
carriage of the organisms in livestock and preventing pathogen dissemination in foods, water and the 
environment. 
The risk of human disease from STEC in the environment accrues from strain characteristics, exposure, 
including  the number of viable organisms present, and host susceptibility.  The monitoring and routine 
surveillance of animals and foods is, therefore, an important strategy in foodborne STEC infections. In 
the EU, the Directive 2003/99/EC establishes criteria for the collection of "relevant, and where 
applicable, comparable data on verotoxigenic Escherichia coli (VTEC) in animals and foodstuffs". 
Technical specifications have been introduced, to provide harmonised data collection for the 
monitoring and reporting of STEC in foods and environmental samples, based on the use of ISO/TS 
13136:2012. The technical approach recommended depends on the detection, by real-time PCR, of 
the major STEC virulence genes (stx1/stx2 and eae) and genes associated with serogroups O157, 
O111, O26, O103 and O145. Any foods found to contain one or both of the stx genes are then 
processed and cultured to attempt to isolate STEC strains. In 2009 a similar method was 
recommended for bovine hides and sheep fleeces (EFSA, 2009). Most recently, following the O104:H4 
outbreak in Germany, the EU expanded the harmonised monitoring to sprouted seeds (EFSA, 2016). 
Current surveillance strategies detect the presence of potential STEC hazards, but for accurate risk 
assessment of contamination, quantitative methods to determine the number of organisms present 
and level of exposure should be undertaken. 
The layered strategy of PCR, followed by culture, substantially improves the surveillance of all STEC 
strains in foods and animals. However, unfortunately many of the strains detected by PCRs for 
the stx1/stx2, eae, and O-antigen genes alone, especially in food and environmental samples, would 
constitute a low risk of human disease. Recent recommendations suggest that the additional genes 
aagR and aaiC are included in PCRs to ensure detection of Stx-producing EAEC strains (EFSA, 2013) 
With the introduction of this much broader based approach in Europe the prevalence of non-O157 
strains in foods and animals is now becoming apparent, even though the role of such strains in human 
disease has yet to be established. Nevertheless,  the ability to identify strains that will cause serious 
disease, for example EHEC strains, and distinguish these from the large numbers of non-virulent 
strains in the same habitats, remains a fundamental surveillance issue.  Interestingly, Delannoy, 
Beutin & Fach (2013) have shown that the combination of the type 111 effector genes espK with 
either espV or ureD or Z2098 can effectively discriminate EHEC from non-EHEC strains and that such 
a targeted approach for the monitoring of meat contamination will reduce the number of false 
positives (Delannoy et al., 2016). 
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The main function of surveillance is to provide an evidence base for the implementation of 
interventions to reduce the public health burden and to monitor the effectiveness of such 
interventions. The infectious dose for EHEC is in the order of only hundreds of cells and such a small 
infectious dose constitutes a significant challenge for risk management. Hazard Analysis Critical 
Control Points (HACCP) is the major tool used by the food industry to prevent and control 
microbiological hazards in the food chain. HACCP aims to ensure good personal hygiene, separation 
of uncooked from cooked foods and the use of suitable storage and cooking temperatures where 
appropriate. However, despite the introduction of substantial regulation and training, human failure 
still occasionally results in significant outbreaks (Pennington, 2010). Thus risk management of STEC 
strains in foods remains a challenge. In the USA E. coli O157 contamination of ground beef is not 
tolerated and results in immediate recall. In the EU, Article 14 of Regulation (EC) No 178/2002 
prohibits food being placed on the market if it is unsafe. Food is deemed to be unsafe if it is considered 
to be injurious to health or unfit for human consumption. Currently an EC guidance document is being 
drafted to assess the risk and determine the risk management strategies for STEC-positive food 
samples 
(http://www.origingi.com/images/stories/PDFs/English/Lobby/Regulatory_issues/Draft_VTEC_guid
ance_document_on_application_Art_14_GFL_REV_3-3.pdf). 
To date most interventions have been targeted at bovines, even though small ruminants are also 
commonly colonised. The contribution of “Super shedder” cattle to the risk of carcass and 
environmental contamination, as well as the risk of horizontal transmission within a herd, has 
highlighted the need for focussed interventions (Arthur et al., 2009; Arthur et al., 2010; Cobbold et al., 
2007; Low et al., 2005; Matthews et al., 2006; Omisakin, MacRae, Ogden & Strachan, 2003). "Super 
shedders" shed at least 104 CFU/g in their faeces, constitute about 2% of cattle herds and generate 
the highest public health risk. Super shedding appears to be a reflection of host properties, such as 
site of colonisation rather than the STEC strains shed (Arthur et al., 2013), but may not be a constant 
state in individual cattle (Munns et al., 2015). 
Finding ways of preventing or reducing STEC colonisation, particularly in cattle, remains a huge 
research challenge despite considerable effort to date. In 2012 Thomas and Elliott systematically 
reviewed interventions for diarrhoea-associated HUS. Interventions aimed at reducing animal carriage 
assessed included biosecurity/farm practices, vaccination, diet, bacteriophages, probiotics and other 
feed additives. This systematic review concluded that "vaccination and improved farming and feeding 
practices, including dietary manipulation (e.g. probiotics and sodium chlorate feed additives), 
cohorting of animals and dry bedding and soil solarization reduce STEC carriage and faecal shedding 
in animals, and hence the risk of STEC transmission to humans." (Thomas & Elliott, 2012). In a 
subsequent systematic review of potential interventions (Wisener et al., 2015), the probiotics 
Lactobacillus acidophilus (NP51) and Propionibacterium freudenreichii (NP24) fed pre-harvest were 
found to significantly reduce faecal E. coli O157 shedding in beef cattle during field trials. Such 
evidence supports suggestions that the diversity and composition of the cattle gut microbiome are 
important factors in controlling pathogen carriage (Munns et al., 2015). However, variation in feeds 
and administration of probiotics had little, if any, positive effect on "Super shedders" in other studies 
(Spencer, Besser, Cobbold & French, 2015). Thus the relationship between gut microbiome, diet and 
STEC carriage requires considerable further investigation. 
Faecal contamination of meat usually occurs during animal slaughter. Poor slaughter practices, 
abattoir hygiene and animal handling practices all contribute to the risk of contamination. 
Understanding the routes of contamination has enabled guidelines to be established to minimise meat 
contamination by pathogens including STEC (ftp://ftp.fao.org/docrep/fao/007/y5454e/y5454e.pdf; 
http://www.fao.org/fileadmin/user_upload/agns/pdf/FAO_E.Coli_FCC_2011.06.231.pdf).  
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Cattle hides are a particular source of carcass contamination and the levels of STEC on hides at 
slaughter are a good predictor of meat contamination after processing (Wheeler, Kalchayanand & 
Bosilevac, 2014). Interestingly the diversity of the commensal microbial population of cattle hides 
appears to be important in determining the risk of contamination with STEC strains (Chopyk et al., 
2016). The food industry has developed a number of interventions targeted at hide decontamination 
in the abattoir, especially the use of rectal ties, de-hairing and improved methods of hide removal, 
and antimicrobial treatments, including washing with water, selected chemicals and organic acids and 
bacteriophages (Loretz, Stephan & Zweifel, 2011; Wheeler et al., 2014).  
STEC successfully survive and persist in multiple, frequently hostile, environments during food 
production and processing as well as in the wider livestock environment. This success is dependent on 
an ability to rapidly sense and respond to specific environmental hazards. To date multiple stress 
response mechanisms have been described (Vidovic & Korber, 2016), which enable STEC such as E. 
coli O157:H7 to respond to acid, heat, cold and oxidative stressors, and are potentially associated with 
an increased virulence. Variations occur in both the range of mechanisms utilised by individual strains 
to respond to environmental stresses and the effectiveness of such responses. Understanding the 
molecular basis of such responses is important so that effective strategies to control STEC can be put 
in place, particularly during food production. This is especially important given that some STEC strains 
can develop tolerance to disinfectants widely used in the farming industry as well as to organic acids 
used as decontaminants during meat processing (Lajhar, Brownlie & Barlow, 2017).  
Although available interventions can reduce STEC contamination in meat products (Pollari et al., 
2017), the public health burden remains high, leading to suggestions that complementary control and 
prevention methods to reduce environmental contamination from colonised ruminants is required 
(Smith, 2014). Vaccination is one obvious complementary strategy, which would reduce STEC carriage 
by cattle on-farms and thereby reduce environmental contamination. Considerable attention has 
been given to the development of such vaccines over the last 2 decades. The review by Smith (2014) 
provides a comprehensive description of the various laboratory-based studies and field trials on 
vaccination against E. coli O157 to that date. Despite the absence of disease, cattle elicit both innate 
and acquired immune responses to STEC colonisation. A number of STEC O157 antigens have been 
identified as potential vaccine candidates and subunit vaccines. To date two vaccines have been 
developed and licensed; Econiche (Econiche Corp, Belleville, Canada), is based on type III secreted 
proteins (T3SPs) and Epitopix (Willmar, USA) comprises cell membrane extracts prepared from iron 
restricted cultures (Corbishley et al., 2016). Although both vaccines induce antibody responses 
effective in significantly reducing colonisation they are only partially protective (Snedeker, Campbell, 
& Sargeant, 2012).  
Considerable research effort is going into the development of new vaccines by identifying alternative 
vaccine candidates, such as flagella, the EhaB autotransporter protein and proteins associated with 
T3SS-mediated adherence (Mahajan et al., 2009; McNeilly et al., 2010; Wells et al., 2009). In addition, 
efforts have been undertaken to improve vaccine efficiency, such as by including vaccine candidates 
that induce a cellular response (Corbishley et al., 2016). The on-going mining of WGS data (Lupolova, 
Dallman, Matthews, Bono & Gally 2016) may allow vaccine development to focus on vaccine 
candidates expressed only by virulent STEC.  
 
Over the last 3 decades, many potential interventions have been investigated and used to reduce 
human STEC infection at various levels in the food chain. However, the burden of disease remains high 
and there is some evidence that implemented interventions may be associated with shifts in both 
infecting strain subtypes and in sources of infection. For example (Adams et al., 2016) investigating E. 
coli O157:H7 infections in the UK during 1983-2012 observed no difference in incidence despite the 
multiple interventions implemented but did observed a shift in subtype (PT2 to PT21/28) and a change 
in observed sources from contaminated meat/milk to petting farms and school/nursery outbreaks.  
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6. Detection, diagnosis and subtyping 
E. coli are easily cultured on general media (such as MacConkey agar) at 37oC under aerobic 
conditions. Enterobacteriaceae are simply identified using commercial biochemical test strips. The 
traditional diagnostic approach involves the culture of faecal samples on chromogenic agar selective 
for E. coli O157, which is generally sorbitol negative, using media such as MacConkey-Sorbitol agar 
or CHROMagar O157. However, the identification of sorbitol-fermenting STEC O157:H7 strains, and 
the increasing awareness of non-O157 STEC strains causing disease, means that the use of sorbitol 
fermentation is not a reliable phenotype for STEC screening (Gouali, Ruckly, Carles, Lejay-Collin and 
Weill, 2013). Moreover, culture takes up to 5 days to provide results (if enrichment is required), which 
in a clinical setting could constrain treatment and endanger lives. More recently clinical laboratories 
have adopted Polymerase Chain Reaction (PCR) techniques with primers for specific targets including 
the stx genes and usually with subsequent culture. This approach generates a positive result for all 
STEC within 1-2 days.  
Being able to reliably predict the severity of an STEC infection could have a significant influence on 
treatment and impact on clinical outcome. It has long been recognised that infection with certain 
STEC seropathotypes could have more serious outcomes (Karmali et al., 2003). However, 
retrospective studies have concluded this classification neither defines STEC pathogenicity nor 
includes all potential pathogenic STEC strains (EFSA, 2013; Messens et al., 2014). Nevertheless, 
strains that represent the highest risk of severe disease appear to largely belong to serogroups O157, 
O26, O103, O145, O111 and O1O4 and are positive for the genes eae or aaiC/aggR, in addition to 
stx2. Most recently positivity for the stx2a gene has been described as an indicator of severe disease 
potential (Byrne et al., 2014). Thus diagnostic PCR tests should include primers for at least this 
minimum set of virulence factors. However, the full complement of factors important in severe 
infections has yet to be established. Moreover, because stx gene-containing phages may exist in 
faeces and environmental samples, such as food and water, using PCR as the primary indicator of 
STEC infection or environmental contamination may generate positive results, which have no clinical 
relevance or risk to humans (Martinez-Castillo & Muniesa, 2014). 
Serology can also be used to diagnose infection. Both innate and adaptive immune responses are 
elicited by STEC-infected individuals. Serological investigations of outbreak subjects have 
demonstrated that humoral and mucosal IgG, IgM and IgA antibodies specifically directed against STEC 
antigens are detectable in serum and saliva (Chart & Cheasty, 2008), consistent with intestinal 
bacterial pathogen colonisation. However, the kinetics, isotype, specificity and protective capacity of 
such antibody responses in humans remain largely un-investigated. Despite this, serology has been 
recommended for diagnostic purposes particularly in children (Desin, Townsend & Potter, 2015) even 
in the absence of detectable bacteria or Stx in faeces (Chart, Cheasty, Cope, Gross & Rowe, 1991).  
Antibody specificity is directed against a range of STEC antigens including LPS O antigens, flagella, Stx1 
and Stx2, and intimin. The anti-O antigen response is directed against both conserved epitopes in the 
core LPS and serotype-specific epitopes. Thus serodiagnosis can apparently be used to detect both 
putative STEC infection and the serogroup of the infecting strain (Chart & Cheasty, 2008). 
The differentiation of E. coli isolates, firstly into different pathotypes and then into subtypes, should 
enable appropriate clinical treatment to be initiated quickly, provide some indication of prognosis and, 
in the case of outbreaks, inform strategies for control and intervention. Because of its public health 
prominence, surveillance for STEC infections is particularly important to detect outbreaks and to 
differentiate strains with the potential to cause severe symptoms.  
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The most definitive approach for the diagnosis of STEC infection is the detection of Stx expression in 
isolated E. coli strains or directly in faecal material. Stx detection is still occasionally undertaken by 
observation of the effect of bacterial supernatant on Vero cells (Verotoxigenic effect) but this is labour 
and resource intensive and nowadays immunoassays are more frequently used. However, most 
laboratories prefer to detect the presence of the stx1 or stx2 genes, usually by PCR, rather than the 
expression of the toxin. 
To ease routine diagnosis, biotypic culture-based methods have been developed for E. coli 0157:H7, 
which characteristically lacks B-glucuronidase activity (GUD-) and is unable to ferment sorbitol (SOR-) 
(Paton & Paton, 1998). Based on such specific metabolic characteristics culture media, such as sorbitol 
MacConkey (SMAC) agar and CHROMagar STEC medium (de Boer et al., 2015), are routinely used in 
public health laboratories for preliminary diagnosis of E. coli O157:H7 strains. With increasing 
availability of whole genome sequences of E. coli strains genome scale metabolic models, initially 
confined to commensal strains, are now being extended to pathogenic strains (Baumler, Peplinski, 
Reed, Glasner & Perna 2011). Such models will contribute to an even greater understanding of the 
biochemistry and physiology of STEC and could aid the development of improved culture-based 
detection methods   
The subtyping of STEC strains enables the (1) tracing of sources and routes of transmission of human 
infections, (2) the identification and monitoring, both temporally and geographically, of specific strains 
with important phenotypic characteristics and (3) the development of strategies to control organisms 
within the food chain. 
The population structure of E. coli is heterogeneous and many subtyping methods have been applied 
to this species and its pathotypes. The current criteria for an effective bacterial subtyping method 
includes cost, speed, accessibility, typeability, discriminatory power, reproducibility, epidemiological 
relevance and phylogenetic relevance. Subtyping methods applied to STEC strains currently include 
the phenotypic approaches of serotyping and phage typing and the genotypic approaches, such as 
virulotyping, pulsed field gel electrophoresis (PFGE), multi-locus sequence typing (MLST), microarrays 
and, most recently, WGS. Different subtyping methods may be advantageous for different purposes, 
for example where reagents are already available and time is not critical but high throughput is 
required, simple serotyping will have advantages over sophisticated genotypic methods but where 
high discriminatory power is critical, say for outbreak investigation, then WGS is probably now the 
method of choice.  
The relationship between the serotype and pathotypes of STEC is well recognised (Karmali et al., 
2003). Although it is now widely accepted that this correlation is imperfect, most public health 
laboratories rely on serotyping. However, the number of O-non-typeable strains reported in 
surveillance studies, suggests that the collection of anti-O-antisera is insufficient to cover the whole 
E. coli population. For example, in 2015, 11.9% of STEC strains isolated in the EU and submitted for 
typing were untypeable, while a further 1.2% were designated O-rough. Reports of the increasing 
prevalence of O-untypeable strains isolated (EFSA, 2016) and the evolution of the E. coli population 
causing shifts in the serotype, raises questions about the continued usefulness of this phenotypic 
subtyping method (Ingle et al., 2016). H antigen typing also has limitations. Often H antigen typing is 
not undertaken because of lack of sera or the presence of non-motile strains (Beutin & Strauch, 2007). 
Nevertheless, the wealth of historical information on STEC strains is serotype-based and the simplicity 
of the agglutination assay enables its worldwide application, and should ensure its continued use at 
least while antisera remains widely available.  
Phage typing of STEC also facilitates public health surveillance and outbreak investigations and has 
been used to categorize sporadic cases. Certain phage types are more likely to occupy specific niches 
and are associated with specific age groups and disease severity (Cowley et al., 2015). STEC phage-
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typing is based on the use of 16 bacteriophages including 14 T4 phages and 2 T7 phages A phage 
infection profile, indicated by the level of lysis achieved with each phage (Ahmed, Bopp, Borczyk and 
Kasatiya, 1987), is generated for each strain. Approximately 80% of all STEC O157 strains typed are 
phage type (PT) 8, 21/28, 2, 4 or 32 in the UK (Gastrointestinal bacteria reference unit (GBRU)). 
(Cowley et al., 2015). Certain PTs are more likely to be associated with human infection but so far 
there is little understanding of the basis for this. 
With the advent of Next-Generation Sequencing, forgoing time-consuming Sanger-based methods 
and improving read lengths of second generation methods, the delivery of the DNA sequence of 
fragments of pathogen genomes, or even whole genomes has become a cheap, rapid and routine 
occurrence. This has enabled the mining and exploitation of DNA sequences for genomic pathogen 
detection, identification and characterisation.  
MLST, based on the partial sequences of 7 housekeeping genes, has been a useful genetic tool for 
understanding the population structure of E. coli. Early studies demonstrated the clonality of some 
serogroups, such as E. coli O157:H7 (Noller et al., 2003) and the technique was subsequently used for 
epidemiological investigations. Five cryptic MLST-based clades were identified (Walk et al., 2009) but 
the pathotypes were distributed throughout the phylo groups, which is unsurprising as the stx genes 
were located in prophages and remain mobile elements.  
Increasing awareness of the plasticity of the E. coli genome and evidence that STEC evolution is 
characterised by the acquisition of numerous virulence factors through horizontal gene transfer 
mediated primarily by bacteriophage transduction (Reid, Herbelin, Bumbaugh, Selander & Whittam, 
2000; Vanaja et al., 2013; Whittam, Reid & Selander, 1998), with subsequent gene gain or loss through 
duplication or deletion (Kaper, Nataro & Mobley 2004), combined with the reduced cost and improved 
computer algorithms for comparison, has most recently shifted the approach to WGS typing, 
especially as in silico MLST could be undertaken with the same data (Lukjancenko, Wassenaar & 
Ussery, 2010). The potential of WGS for microbial subtyping has recently been reviewed (Perez-Losada 
et al., 2017) and the technological requirements for this will be addressed in Section 7. 
Whole genome sequencing is now widely accessible and affordable. Early comparative genomic 
studies showed a surprising level of genetic diversity within the E. coli species (Lukjancenko et al., 
2010). The core genome of E. coli comprises 1996 genes, which is only 37-49% of the genomes of 
individual strains (Holmes et al., 2015). This number of genes is expected to fall as more strains are 
sequenced. Strains from different E. coli pathotypes tend to be from different major phylogenetic 
clades, suggesting that virulence is endowed by the variable genes constituting the remainder of the 
pan-genome.  
Whole genome sequences of strains within the STEC population are also genetically diverse and once 
again there are no absolute correlates with disease outcome. Nevertheless, recent phylogenetic 
studies have established that E. coli O157:H7 can be categorised into three main lineages and nine 
clades (Shaaban et al., 2016) with disease and geographical relationships. Although more severe 
human disease is associated with strains of lineage 1/11 clade 8 in the USA, most clinical isolates 
belong to lineage I clade 4/5 in the UK (Dallman et al., 2015b). 
 Whole genome sequencing can also provide in silico information about both O and H serotype by 
targeting genes involved in surface antigen synthesis, the wzx/wzy and fliC gene sequences 
respectively, (DebRoy et al., 2004; Ingle et al., 2016; Wang, Curd, Qu & Reeves 1998). On the basis of 
cost, speed and availability such molecular serotyping may rapidly replace conventional serotyping 
(Delannoy et al., 2017).  
WGS can also provide additional information on virulence and antibiotic resistance genes (Ferdous et 
al., 2016). Moreover, WGS enables a rapid understanding of strain evolution via horizontal gene 
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transfer. For example, in the German STEC outbreak of 2011 there was a transduction of an EAEC 
O104:H4 strain with Stx phage (Rasko et al., 2011) to produce a novel virulent STEC strain. For 
epidemiological purposes it would seem that the WGS approach is useful for detecting time-restricted 
outbreaks but, because of the possibility of gene uptake or loss, not necessarily for the comparison of 
strains from different outbreaks or the tracing of infection sources unless deep analysis is undertaken.  
Clearly WGS, providing a wealth of molecular information for clinical, epidemiological and research 
purposes is now the optimal approach to STEC strain characterisation. However, the approach raises 
a number of issues, which will need to be addressed. In particular, there is an urgent need to develop 
bioinformatics tools and expertise to interpret and utilise the information being produced in huge 
quantities (the mining of ‘big data’). There are also concerns regarding the storage space required, 
ownership, security and ethics of the genomic data. Finally, consideration should be given to the 
implications for historical and current collections of STEC strains. Although, the long-term storage of 
strains is costly and time consuming, the live organism provides invaluable phenotypic information 
that cannot be replaced with just a genome sequence.   
 
7. Rapid detection and diagnosis  
Speed can be essential in the diagnosis of human STEC infection as generally antibiotic therapy is 
contraindicated if an infection is caused by an EHEC strain. However, improved test speed is often at 
the cost of sensitivity and specificity. A major issue for the development of rapid tests is that STECs 
predominantly resemble commensal E. coli, both phenotypically and genotypically. Furthermore, they 
are often only a minority population among patient faecal coliforms.  
Rapid tests are also important for environmental specimens to enable epidemiological tracing during 
outbreaks and the monitoring of food contamination in the production line. In such samples viable 
STEC are often present in even smaller numbers. In addition not all STEC strains have the same capacity 
to cause severe disease or present a public health danger. Therefore, the problems facing 
microbiologists are twofold: first, they must established whether STEC are present in a given sample 
and second, they need to establish whether this is a substantial disease risk by isolating and/or 
identifying and characterising the STEC present in the sample.  
To date the development of methods of STEC detection have largely focussed on E. coli O175:H7 and 
these have been recently reviewed by Wu, Hulme & An (2015). In this section we will focus on those 
techniques, which (sometimes with modification) enable the rapid detection of all STEC infections in 
humans, their carriage by animals and their contamination of foods. Apart from E. coli O157:H7 the 
serogroups considered important causes of STEC infection in humans are O26, O45, O103, O111, O121 
and O145: together these are often referred to as the "Top 7 STECs".  
7.1 Culture dependent methodologies 
Culture remains the "Gold Standard" for the detection of STEC in clinical and environmental samples 
and, with the advent of numerous chromogenic agars and antibody-bead retrieval systems, it is still 
the method of choice for many diagnostic laboratories. However, culture does have a number of 
disadvantages. These include the ability to detect only viable organisms, the potential for normal flora 
to mask STEC growth, the relatively low limit of detection, the time required (24-48hrs) to obtain a 
definitive diagnosis and the additional procedures needed to obtain serotype, virulotype or 
antimicrobial resistance (AMR) information. Antimicrobial treatment is generally contraindicated for 
patients with EHEC infections, however when antimicrobials are required they should be appropriately 
targeted so that unnecessary selection of resistance in residual flora is avoided. The generation of 
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antimicrobial resistance in STEC might also be detrimental to the implementation of some novel 
control strategies for example the direct application of antimicrobials to the terminal rectum of 
colonised cattle (Naylor et al., 2007). Because culture is labour intensive, expensive and time 
consuming, there is an urgent requirement for rapid, economic tests. 
 
7.2 Non-culture dependent methodologies 
 
The effectiveness of rapid microbiological diagnostic and detection tests depend on a number of 
factors including the type of microbial target, its surrounding environment, the expertise of the 
laboratory, etc. For the purposes of this review such tests will be divided into immunologically-based 
or genetically-based methodologies. 
 
7.2.1. Immunologically-based methods: 
Immunomagnetic separation (IMS) significantly increases the speed and sensitivity of detection of 
STEC, particularly for bacterial isolation and culture from complex matrices such as faeces and ground 
beef. Although, the efficacy of all immunologically-based tests is highly dependent on the specificity, 
clonality, isotype and kinetics of the antibodies used, insufficient consideration is often given to this 
test component. For IMS, the detection of all major serogroups of STEC requires treating each sample 
individually with serogroup-specific beads. Such a labour-intensive and time-consuming procedure 
can now be modified by combining serogroup-specific beads without loss of sensitivity (Noll et al., 
2016).  
A number of antigen-capture indirect and direct enzyme-linked immunosorbent assays (ELISAs) are 
commercially available as test kits for a range of applications in STEC detection including food 
monitoring and organism detection in human or animal faecal material with or without prior 
enrichment. Some of these test kits claim quantitative as well as qualitative outputs. In recent years 
considerable research effort has gone into increasing test kit speed, ease of use and sensitivity by 
improving the enrichment and preparation of samples, for example by immunomagnetic bead 
recovery, and by amplifying the detection signal. The development of nanotechnology has been 
particularly successful for this purpose. For example, by combining immunomagnetic separation and 
functional nanoparticle-enhanced ELISA (FNP-ELISA), detection levels for E. coli O157:H7 of less than 
1000 cfu/ml in foods is achievable (Shen et al., 2014) with a test time of approximately 3 hours.  
However, such a level of sensitivity is often too low for detection to be practical, for example in many 
foods. Sensitivity can be a problem with this approach, especially if there is cross reactivity or other E. 
coli are present which might overgrow low numbers of pathogenic bacteria. 
The presence of Shiga toxin in faeces is time limited during infection, however, this approach, with or 
without culture, is often used in suspected cases of HUS to ensure the rapid application of appropriate 
treatment. Stx expression levels vary between strains but can be upregulated by exposure to 
mitomycin C or polymyxin B during enrichment. However, until recently the ability of immunosorbent 
assays to detect all forms of Stx1 and Stx2 has been a significant problem (Wu et al., 2015). In 2016 
the development of new antibodies was described (He, Kong, Patfield, Skinner & Rasooly 2016) 
directed against all the known subtypes of both Stx1 and Stx2, which substantially increased the 
sensitivity of ELISA for STEC strains both on cultured isolates and in ground beef samples. 
With the availability of suitable polyclonal and monoclonal antibodies, the commercial test kit 
platforms currently used for E. coli O157:H7 detection, should become available for the "top 7 STECs". 
Many such kits have been developed and commercialised and marketed largely on the basis of speed. 
However, the performance characteristics of such tests, especially in terms of sensitivity, varies 
enormously and is often substantially poorer than culture. Also many of the modern immunologically-
based test platforms are highly specialised, tying laboratories into long-term investments which may 
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not be economic. Choice of platforms should take into account sample type, through put and 
technological competence available. Wu et al., 2015 have reviewed several of the recently developed 
immunoassay platforms adapted for detection of E. coli O157:H7, with improved sensitivity based on 
approaches such as peptide nucleic fluorescence in situ hybridisation and improved ease of used 
based on microfluidics.  Most recently novel platforms developed have included electrochemical 
immunosensors (for example Güner, Çevik, Şenel & Alpsoy, 2017) and lateral flow immunoassays, 
which increasingly exploit nanotechnology to improve reporter sensitivity (for example (Cheng et al., 
2017). Such technologies will enable portability into the field as well as robustness and ease of use for 
unskilled workers. 
7.2.2 Genetically-based methods: 
 
7.2.2.1. PCR and DNA hybridisation-based assays 
Most of the methods currently used to detect STEC in faecal specimens or food, involve DNA-based 
techniques. Overall, PCR-based methods have been most widely applied. In these assays, short 
sections of the DNA specific for the stx genes are usually selected and specific oligonucleotides 
(primers) used to amplify specific sections of these genes (Bettelheim & Beutin, 2003). Some PCR 
assays have also aimed to detect the serotype (Anjum, Tucker, Sprigings, Woodward & Ehricht, 2006; 
Maurer et al., 1999; Paton & Paton, 1999). PCR is rapid, cheap and these days widely accepted and 
utilised in routine laboratories and, with careful primer choice, can be adapted for the detection of 
multiple DNA targets at one time. However, the reliance on PCR only for STEC diagnosis or detection, 
especially using primers for stx genes, is questionable (Martinez-Castillo & Muniesa, 2014) given that 
free stx-phages may be present in faeces and environmental samples to interfere with the results. 
Similar caveats apply to the reliance on the presence of stx genes in whole genome sequences. 
Modification of sample preparation could reduce such interference (Martinez-Castillo & Muniesa, 
2014). 
Although the simple presence of EHEC strains is sufficient evidence of food contamination, in some 
countries, for the accurate assessment of public health risk a quantitative approach is necessary. 
Enumeration by the Most Probable Number (MPN) method is both tedious and time consuming. 
Quantitative PCR (qPCR) methods have now been developed to enumerate STEC in samples, such as 
milk, providing rapid and accurate results (Mancusi & Trevisani, 2014).  
DNA arrays, however, are most useful for the detection of large numbers of different DNA targets. 
Such arrays are based on the detection of DNA hybridisation to multiple target DNA sequences. The 
development of miniaturised arrays (Anjum et al., 2007) with wide panels of virulence and 
antimicrobial resistance (AMR) genes has enabled the rapid characterisation of E. coli strains, including 
STEC (Bekal et al., 2003; Bruant et al., 2006; Anjum et al., 2014; Szmolka, Anjum, La Ragione, 
Kaszanyitzky & Nagy, 2012). Such arrays provide a practical high through-put tool for detecting 
pathotypes and antibiotic resistance mechanisms. 
PCR has been adapted by combination with ELISA (Fach, Perelle, Grout & Dilasser, 2003) to develop a 
detection method for STEC in clinical samples. The principle of the method is the incorporation, during 
the PCR amplification process, of digoxigenin-labelled dUTP and a biotin-labelled primer specific for 
the stx genes. The labelled PCR products, bound to streptavidin-coated wells of a microtitre tray 
through the biotin, are then detected by an ELISA technique. PCR-ELISA has the advantages of 
specificity and sensitivity over standard ELISA as well as removing the need for specific antibodies or 
purified antigens. PCR-ELISA also provides opportunities for automation and improved test times over 
standard PCR. 
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The development of real-time PCR techniques has been of significant advantage and these have been 
applied to detect a number of pathogens. Real-time PCR has been used to detect and quantify STEC 
strains of serogroups O157, O111 and O26 in both beef and bovine faecal specimens (Sharma, 2002). 
Reverse transcriptase PCR designed to detect viable STEC has also proved useful (McIngvale, Elhanafi 
& Drake, 2002). Quantitative PCR assays have also been widely employed to determine the levels of 
colonisation and/or contamination in various samples (Verstraete et al., 2014). 
7.2.2.2. LAMP technology 
 
Loop-mediated isothermal amplification (LAMP) is a novel isothermal nucleic acid amplification 
method with high specificity, efficiency, and speed. It has been employed for the detection and 
identification of bacteria, fungi, viruses, and parasites. The LAMP assay utilizes simple and inexpensive 
laboratory equipment and, as a result, has been investigated as a potential molecular point-of-care 
diagnostic tool. Detection methods, including the use of turbidity (based on magnesium 
pyrophosphate generation during the reaction), fluorescent dyes (calcein and SYBR-1) and 
complexometric detectors, such as hydroxynaphthol blue, have all been explored for the detection of 
LAMP reaction products. Recent advances in genome sequencing technology enable primers to be 
designed on pan-genomes generated from multiple strains, thus increasing specificity. LAMP can 
detect between 5 – 10 organisms in a swab sample and is therefore considered to have superior 
sensitivity to culture or PCR based diagnostics (Diribe et al., 2014; La Ragione, R.M., personal 
communication). LAMP assays have been designed on a number of targets, including; rfbe for 
Enterohemorrhage E. coli, Z3276 gene for the detection of E. coli O157:H7 and stx1 with stx2 for Shiga 
toxins. Recent advances have also combined LAMP with propidium monoazide (PMA) assays for the 
detection of viable, but non-culturable organisms (Yan et al., 2017; Ravan, Amandadi, & Sanadgol, 
2016). 
LAMP was originally developed by the Eiken Chemical Company (Japan). It relies on auto-cycling strand 
displacement DNA synthesis by a DNA polymerase with strand displacement activity (Bst polymerase). 
LAMP uses a set of four specially designed primers (two sets of inner and outer primers) that recognise 
six distinct sequences within the target DNA. LAMP reactions are initiated by the inner primers, which 
contain sequences of both the sense and antisense strands of the target DNA. The outer primers prime 
the initial DNA synthesis step, leading to the release of single stranded DNA. The released single 
stranded DNA is primed by the inner and outer primers and serves as a template for the synthesis of 
a stem loop DNA structure with self-priming capabilities. Generation of this stem loop structure is an 
essential part of the amplification process. 
LAMP reactions are typically performed at 60oC – 65oC, the optimum temperature for the polymerase 
used, as well as the temperature at which double and single stranded DNA are in dynamic equilibrium 
(Mori, Nagamine, Tomita & Notomi, 2001). The single temperature required for LAMP reactions 
enables simple equipment, such as temperature controlled heat block or water bath to be used. Under 
ideal conditions, a few copies of DNA can be amplified to 109 copies in less than an hour (Notomi et 
al., 2000). A number of LAMP assays have been developed for the detection of STEC in clinical samples 
(Dong, Cho, Hahn & Cho, 2014; Wang, Jiang & Ge, 2012; Wang, Jiang, Yang, Prinyawiwatkul & Ge, 
2012). 
There are multiple techniques for the detection of LAMP amplicons, but for real-time analysis, the 
LAMP reactions can be performed on a real-time PCR thermocycler, using the following cycling 
conditions:  A constant temperature of 65°C for a set period of time (time depends on specific assay), 
followed by a 60 second period with a stepwise increase of temperature from 65°C to 96°C. 
Fluorescence is measured in both periods, with the melting temperature of the amplicon calculated 
from the dissociation curve. A reaction is considered positive when the level of fluorescence crosses 
the cycle threshold (CT), calculated for example by the MX3000p analysis software (Agilent 
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Technologies, UK). Once validated using RT-PCR, the tests can also be performed on the Genie 
machine, suitable for any basic laboratory with very little training. 
LAMP amplicons can also be detected using a Lateral Flow Device (LFD). For LFD mediated detection 
of LAMP reactions, minor modifications to the “loop” primers are required. The loopF and loopB 
primers are labelled at their 5' ends with fluorescein isothiocyanate (FITC) and biotin (Btn), 
respectively. The LFD device contains latex beads conjugated with anti-Btn antibodies, a test line (T-
line) embedded with anti-FITC antibodies and a control line, that captures the latex beads, embedded 
with anti-Btn. For a positive LAMP reaction, where both labelled primers are incorporated into the 
amplicon, the Btn in the amplicon binds to anti-Btn embedded in the latex beads. On reaching the test 
line, the anti-FITC embedded in the test line binds to the FITC portion of the amplicon, while free and 
mobilised beads are trapped on the control line. In the absence of the target DNA, where no amplicon 
is produced (a negative reaction), there is no co-localisation of the antigen-antibody complex formed 
by the amplicon and latex beads on the test line of the LFD. PCRD-2, is a commercial sandwich 
immunochromatographic LFD, which specifically captures double stranded amplicons that contain 
both FITC and biotin (Pocket Diagnostics, UK). 
The efficiency and speed of LAMP technology means that tests can detect STEC infections and provide 
information on, for example AMR profiles, in less than 15 minutes, directly from a swab, with excellent 
specificity and sensitivity (Diribe et al., 2014; Diribe, Thomas, AbuOun, Fitzpatrick & La Ragione, 2015). 
 
7.2.2.3. Direct Next Generation Sequencing (NGS) approaches 
Improved DNA sequencing methods have transformed the field of genomics over the last decade. This 
has become possible due to the development of inexpensive sequencing technologies, which have 
now resulted in four generations of sequencing platforms (Cherukuri & Janga, 2016). These NGS 
technologies have now been adapted for the diagnostic laboratory environment and can be used on 
pure cultures as well as mixed cultures/samples (Dallman et al., 2015b; Schmidt et al., 2017). 
 
There are a number of NGS technologies already in use in diagnostic microbiology laboratories but 
most require specialist staff especially for analysis of the data. However, the recent development of 
the Oxford Nanopore Technology's MiniION sequencing device offers a patient-side personalised 
medicine solution. This technology is based on protein nanopores that are set in an electronically 
resistant membrane. An ionic current is sent through the nanopore by setting a voltage across the 
membrane. When a DNA strand is passed through the nanopore the current makes is possible to 
identify which nucleotides are passing through. This technology has already been applied to direct 
sequencing of pure and mixed bacterial cultures (Kilianski et al., 2015; Ma, Stachler, & Bibby, 2017) 
and has enormous advantages of robustness, portability and ease of use enabling application outside 
the laboratory - even in outer space 
(https://www.nasa.gov/mission_pages/station/research/news/dna_sequencing). 
 
As mentioned above, the current technologies now allow for direct sequencing from cultures, thus 
providing accurate and detailed genomic data within hours and such direct whole genome approaches 
have already been applied to the diagnosis of STEC and outbreak investigation (Dallman et al., 2015a) 
and to the risk assessment of Stx-producing E. coli in cattle populations (Mainda et al., 2016).  
 
It is easy to envision that in the near future doctors will take clinical samples such as faeces, robots 
will undertake DNA extraction, sequencing will only take a few minutes, and accessory software will 
assist applied bioinformatics to answer specific questions. Thus, within minutes, the presence of a 
pathogen will be confirmed and those genes, if any, which encode for its virulence and antimicrobial 
resistance will be identified. In combination with available patient data, the clinician can then swiftly 
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assess the risk of the infection to a specific patient and determine appropriate therapy. Similar 
technologies will be applicable to food safety and veterinary medicine.   
With such technological advances molecular epidemiology is now able to mine pan-genome rather 
than core genome information for comparative purposes. The increased sensitivity for strain 
differentiation is enormous. However, the practical and philosophical problems associated with 
acquiring, handling and effectively interpreting such a wealth of data have also been, and continue to 
be, enormous, but have only recently been cosidered (Bertelli & Greub., 2013; Del Chierico et al., 2015; 
Kozyreva et al., 2017). There are two overarching problems which need to be addressed. Firstly, 
available microbial WGS data is immense, ever-growing and increasingly complex. The ownership, 
storage, security, quality control and ethics of use of such data needs to be discussed by the scientific 
community preferably as part of a public debate. Part of that debate should be about the impact of 
the major shift from traditional cultural to genomic approaches to infectious disease investigations in 
public health. With such a shift, economic restrictions are beginning to put pressure on the retention 
of new strains and historical strain collections. The assumption that WGS will provide all the 
information required and that all phenotypic properties will have little future value is at best naive 
and at worse foolish because bacteria will always evolve to surprise us.  
 
The second major problem is the how to extract required and worthwhile information from this huge 
data pool. For the purposes of this review there appears to be one overall question: "Can we predict 
from WGS which STEC strains constitute a risk of serious human disease?" Of course within that 
question there are many others such as "Can we differentiate STEC strains of difference levels of 
virulence?" and "What is the distribution of virulence properties within strains of individual STEC 
serotype or from specified sources?". Such questions can only be answered if the available data is 
sufficiently comprehensive. There is a clear and urgent need for large databases of fully closed 
genomes of strains that are well described in terms of source, disease association, etc. It is important 
that such strains are collected from across the world, from multiple host species and environments 
and represent historical strain collections as well as ongoing surveillance. This will need considerable 
investment and the requirement for the collection and curation of WGS data on strains at the national 
and international levels.  
Currently few laboratories have the expertise to interpret WGS data. Interrogating WGS databases to 
generate useful information has become a highly specialised skill of bioinformaticists who have 
developed multiple highly complex computer-based processes and tools, and a sophisticated jargon, 
to undertake this task. Bioinformatics pipelines, which are the logical ordering of multiple computing 
procedures automatically undertake all base calling analyses, sequence assembly of reads and gene 
identification. Such platforms, taking the raw WGS data and processing it for comparative genomics 
and data interpretation, are beginning to replace the tedious and time-consuming process of manual 
data handling (Kilianski et al., 2015). However, there are many such pipelines described and to date 
no standard workflow language has been adopted so that this area of expertise has become 
increasingly specialised. Frequently, there is limited understanding of how the data has been handled 
and the consequences of this on data interpretation. Increasingly such information restrictions, in 
addition to the barriers already existing between expert bioinformaticists and non-expert 
microbiologists/clinicians will limit the application of WGS to clinical decision making.  
 
WGS is likely to be the future for routine STEC detection and diagnosis, especially during outbreak 
investigations, and one major advantage of this technology is its mobility. With the availability of 
miniaturized sequencing technologies, samples taken at the bedside or from the farm could be 
immediately sequenced and analysed with hand-held devices, which will then transmit the data, via 
improving wireless communications, such as 5G, to a central databank for strain comparison. Such a 
technological step change will almost certainly have a huge impact on future epidemiological 
investigations and enable interventions to be rapidly applied. 
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8. Conclusions 
In conclusion, despite considerable progress in the detection and diagnosis of STEC a number of 
research issues remain to be addressed (Table 1).  
Over the last 10 years or so the time required to identify, and even characterise the pathogen in clinical 
material and samples throughout the food chain has reduced from 5 days to a few minutes. Where 
available such facilities have dramatically improved the diagnosis and treatment of patients as well as 
improving epidemiological investigation and the management of microbiological hazards along the 
food chain.  
In recent years the development of novel non-culture based technologies, with high efficiency, speed 
and ease of use, has even enabled the application of point of care tools raising the possibility of 
personalised diagnostics for infectious diseases such as STEC. Such technologies could easily be 
adapted to monitoring in food processing lines.  
Nevertheless, the isolation and culture of organisms will always remain the "Gold Standard" in 
bacteriology and improved culture media and conditions, which will enable the recovery and rapid 
identification of non-O157 as well as O157 STEC are urgently required. The ongoing research using 
metabolic models will certainly contribute to such selective media.  
The benefits of WGS using new generation technologies has provided a significant boost to the 
identification and characterisation of all E. coli and especially STEC. However, such rapidly evolving 
technologies have generated considerable new issues that need to be urgently addressed such as data 
security and interpretation strategies. 
The development of rapid methods to monitor and characterise STEC strains in the food chain and 
environment has limited value unless it is used for the purposes of intervention. Recent studies 
indicate that interventions to reduce STEC entering the food chain have had limited success. Clearly 
there is an urgent need for more research on vaccines, especially in the major livestock reservoir, 
cattle. Unfortunately, the cost of vaccine development for livestock, where the benefit is to public 
health and not the food industry, is unlikely to command priority for funding. Nevertheless, our 
understanding of bovine immunity to STEC is increasing and the discovery of effective antigens, driven 
by WGS data mining, remains a high priority. Alternative innovative and cost effective ways of 
delivering appropriate immunity may also prove effective in the future, such as the generation of 
passive immunity through the consumption of genetically engineered antibodies (Kühne et al., 2004; 
La Ragione et al., 2006).  
Ultimately, although huge progress has been made, STEC still remains a significant zoonotic issue. 
Substantial reductions in the public health burden due to this infection will require a multi-pronged 
approach. The world-wide surveillance in humans, livestock and foods, using diagnostic and detection 
methods with high sensitivity and specificity, in conjunction with high-resolution subtyping of isolates, 
will be required to monitor future progress and detect STEC evolution. Increased awareness and 
education of the general public and food producers will be required to improve food hygiene and on-
farm management and abattoir practices to reduce ruminant colonisation and meat contamination. 
Finally, there is an urgent need to develop appropriate and complementary interventions, including 
vaccines, to control STEC colonisation in livestock and prevent environmental contamination.  
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Table 1: Current challenges for the investigation, control and prevention of STEC and the roles that 
novel and innovative detection, and diagnostic techniques could play in meeting these challenges. 
Research challenge Importance Research required, with 
particular relevance to 
detection & diagnostic 
techniques 
Example 
references 
Prioritise the public 
health burden of STEC 
disease at national 
and regional levels. 
Accurate and timely 
disease monitoring and 
data collection to 
prioritise public health 
and research funding. 
Shift focus from O157 to 
all STEC. Sample collection 
and diagnostic tests that 
are suitable for 
monitoring all STEC 
disease in routine 
laboratories. 
NA 
Provide rapid 
response to STEC 
outbreaks. 
Critical to detection of 
sources, limit outbreak 
and provide appropriate 
clinical care. Must be able 
to detect newly evolved 
strains (e.g. O104:H4). 
Rapid tests of clinical 
disease with broad 
specificity to detect all 
STEC strains. 
NA 
Understand and 
monitor the 
population structure 
of all STEC. 
Essential to 
understanding the 
pathogenicity, 
epidemiology and 
evolution of the 
pathogen. 
Comparative genome 
sequencing of large 
collections of human, 
animal and environmental 
STEC strains. Requires 
large numbers of 
complete and closed 
genomes 
The observation of STEC 
population shifts over 
time require long-term 
monitoring, and accurate 
and relevant subtyping 
techniques.  
 
Adams et al., 
2016 
Determine the role of 
non-O157 strains in 
human disease.  
To inform risk assessment 
models. 
Rapid, economic and easy 
to use laboratory methods 
for recovery, culture, 
detection and subtyping 
of non-O157, as well as 
O157, STEC strains in 
human and animal faeces. 
Frank et al., 
2011 
Severi et al., 
2016 
Define the minimum 
infective dose and the 
variation in dose 
To inform risk assessment 
models. 
Volunteer studies not 
feasible, so 
epidemiological studies 
Teunis et al., 
2008 
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response for human 
STEC infections. 
 required. Rapid, portable, 
quantitative and 
comprehensive detection 
methods applicable for 
detailed epidemiological 
investigation of outbreaks.  
An alternative approach is 
to develop surrogate in 
vivo/in vitro models, with 
evidenced-based 
relevance to human STEC 
disease. 
Newell et al., 
2016 
 
Define and 
characterise the 
virulence 
factors/genes 
essential for severe 
human disease. 
To predict the clinical 
outcome of human 
disease and ensure 
appropriate and timely 
treatment.  
 
Fundamental studies 
required to investigate the 
genetic-basis of virulence 
and then use to develop 
subtyping methods to 
distinguish levels of 
potential virulence in STEC 
strains. 
Beutin et al., 
2008 
Shaaban et al., 
2016  
Franz et al., 
2015 
Delannoy et 
al., 2013 
Prevent the severe 
consequences of 
human infection such 
as HUS. 
Reduce mortality and 
chronic disease 
Rapid, point of care tests 
indicating the level of 
STEC strain virulence, 
degree of colonisation and 
indicating appropriate 
treatments. 
Vanaja et al 
2013  
Kruger and 
Lucchesi, 2015 
Understand the 
genetic basis and 
evolution of antibiotic 
resistance in STEC. 
Antimicrobial treatment 
is generally 
contraindicated for 
patients with EHEC 
infections, however when 
antimicrobials are 
required they must be 
appropriately targeted so 
that the unnecessary 
selection of resistance in 
residual flora is avoided. 
Rapid point of care tests 
should include 
antimicrobial resistance 
targets. 
NA 
Determine and 
prioritise the sources, 
reservoirs and routes 
of transmission for all 
clinically important 
STEC. 
To inform risk assessment 
models, develop 
regulatory frameworks 
and develop/prioritise 
intervention strategies. 
Requires detailed 
epidemiological 
investigation of animals, 
environment, plants etc. 
using detection systems, 
which will quantify and 
subtype all STEC, be 
suitable in all 
environments and provide 
robust comparative data. 
Mancusi & 
Trevsani, 2014 
Understand the 
genetic basis of 
survival and 
persistence of STEC in 
To develop control 
strategies for 
environmental 
contamination 
 Will enable the 
development of tests to 
determine which strains 
will survive on foods etc. 
N/A 
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the environment 
including biofilms. 
and the development of 
appropriate 
decontamination.   
    
Understand the 
mechanisms of 
colonisation of 
livestock by STEC and 
the factors influencing 
colonisation. 
Reducing STEC in the food 
chain is the currently 
available public health 
measure. 
 
Investigation of in vivo 
models expanded to non-
O157 strains.  
Understanding genetic 
basis of STEC colonisation 
and "supershedding" will 
allow suitable tests for 
selection of resistant 
livestock. 
 
NA 
Develop interventions 
to effectively 
reduce/eliminate 
colonisation of 
livestock by STEC. 
Controlling STEC 
dissemination in livestock 
will also reduce 
environmental and thus 
food contamination. 
Rapid, cheap pen-side 
tests which are robust and 
quantitative required for 
determining factors 
including colonisation and 
monitoring effectiveness 
of interventions such as 
vaccines or feed 
supplements such as 
probiotics. 
NA 
Determine the most 
effective vaccine 
candidates  for 
livestock and develop 
appropriate delivery 
systems. 
To provide 
complementary 
control/prevention 
strategies in the food 
chain 
Mining of WGS data 
required to identify 
appropriate antigens 
expressed only by virulent 
STEC. 
Lupolova, 
Dallman, 
Matthews, 
Bono & Gally 
2016 
Investigate safe and 
effective 
decontamination 
methods to be used 
post-harvest and in 
the food chain 
environment. 
To ensure delivery of safe 
food at retail 
Improved recovery 
methods for all STEC 
strains to ensure test 
accuracy to assess 
bacterial survival.  
Rapid quantitative tests 
needed that can be 
inserted into food 
production lines for rapid 
on-line monitoring. 
NA 
Replace time and 
resource consuming 
routine STEC isolation 
techniques.  
The surveillance of STEC 
in humans, foods and the 
environment requires 
diagnostic and detection 
tests appropriate for the 
sample, level of 
information required and 
laboratory conditions.   
Culture remains the "Gold 
Standard" and will remain 
important for many 
For the foreseeable future 
STEC isolation will remain 
important. Low-tech and 
cost effective methods to 
improve STEC recovery, 
speed up culture and 
enable simple 
characterisation are still 
needed  
Increased availability of 
WGS data has enabled 
NA 
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routine public health 
laboratories. 
 
  
rapid and specific 
genome- based tests for 
strain characterisation, 
such as LAMP to be 
developed. Such tests now 
need to be translated into 
low tech practical formats.  
In the near future 
WGS will be the 
preferred route for 
strain identification, 
subtyping and 
virulence assessment 
but what are the 
issues to be addressed 
with WGS to ensure 
best use of this data? 
Modern genome-based 
techniques will provide 
new opportunities for 
improved diagnosis and 
approaches to treatment 
and intervention.  
 
Development of 
international standards of 
interpretation and quality 
control measures 
The storage capacity 
needed, data ownership, 
security and ethics all 
need urgent 
consideration. 
Development and 
availability of 
bioinformatics pipelines 
and platforms using a 
standard language. 
Improved communication 
between expert 
bioinformaticists and non-
expert microbiologists. 
 
Kozyreva et al., 
2017 ; Del 
Chierico et al., 
2015; Bertelli 
& Greub, 2013 
If public health 
laboratories shift to 
WGS for data storage, 
should historical and 
on-going strain 
collections still be 
retained?  
 
Phenotypic and genotypic 
information are 
complementary. 
Phenotypic studies are 
required to ensure rapid 
genetic tests developed 
are relevant and 
appropriate. 
NA 
 
